A
Aramis Biotechnologies
Canadian biomanufcaturing company specializing in the production of innovative plant-based vaccines
About Aramis Biotechnologies
Aramis Biotechnologies, a Canadian company founded in 2023 and based in Quebec City, specializes in the development of a new generation of biomanufacturing platforms using plant-based technology. The company leverages the unique capabilities of plant cells to produce innovative vaccines and biotherapeutics.
The core of Aramis' technology is the use of plants as bioreactors, a method that supports the development of sustainable and effective solutions against various diseases. The company's primary focus is on advancing plant-based vaccines and therapeutics to combat influenza and other infectious diseases. This approach has led to significant breakthroughs in plant-based protein production, positioning the company as a notable player in the biotech space.
Aramis has established a partnership with the Biologics Manufacturing Centre, a collaboration that enhances its manufacturing and development capabilities. The company's structure is also noteworthy, with an employee-shareholder model that fosters a committed and driven team. Through its work, Aramis aims to provide innovative and sustainable health solutions to the global community.
Source: Dealroom company dataNews
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Dec 2024 | $22M | $88M | Undisclosed | ↗ |
| DEBT✓Debt | Dec 2024 | $7.3M | — | Government of Quebec | ↗ |
Growth signals
Latest recorded traffic for Aramis Biotechnologies is 1.5K monthly website visits, up 70.5% over the last three months. Aramis Biotechnologies's team grew 8.7% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Aramis Biotechnologies in the Quebec City ecosystem
The Aramis Biotechnologies office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
Government of Quebec
Other known investors1 additional known investor
Laval University
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Aramis Biotechnologies on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Aramis Biotechnologies’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.










